Almost every claim made for zeolite traces back to a test tube, a dairy cow, or a rat. That is worth saying plainly, because it makes the exception more interesting. In 2015, a randomized controlled trial gave clinoptilolite to aerobically trained adults for twelve weeks and measured intestinal barrier markers, inflammation, redox biology, and performance [1]. It is one of the very few human trials in the entire clinoptilolite literature, and the population it studied, endurance-trained people with a well-documented gut problem, was a sensible choice. Here is what it found and how much weight it can carry.
Key Takeaways
- A 2015 randomized trial supplemented aerobically trained adults with zeolite for twelve weeks and measured gut barrier integrity, inflammation, redox status, and performance [1].
- The intestinal barrier marker is where the reported effect appeared, not performance. Framing zeolite as an ergogenic aid overstates the trial.
- Exercise-induced intestinal permeability is a real, recognized phenomenon driven by blood being redirected away from the gut during hard efforts [2].
- This trial has not been replicated at scale, and one study does not establish a supplement’s usefulness.
- Interventions with far stronger evidence for exercise gut symptoms already exist, including gut training and fueling strategy, and they should come first.
The Problem the Study Was Aimed At
Gastrointestinal distress is one of the most common reasons endurance events go badly. It is not a niche complaint. A systematic review of the gut and exercise relationship documents the range of gastrointestinal disorders associated with physical activity and how consistently they show up in athletic populations [2].
The mechanism is reasonably well understood. During hard or prolonged exercise, cardiac output is redistributed toward working muscle and skin, and splanchnic blood flow drops. The intestinal lining is metabolically demanding tissue, so that relative ischemia stresses it. Add core temperature rise and mechanical jostling, and the tight junctions between intestinal epithelial cells can loosen temporarily, letting more material cross the gut wall than normally would. Researchers track this with markers like zonulin and intestinal fatty acid binding protein.
That is the target the 2015 trial went after. If a binder sitting in the gut lumen could reduce the local irritant load, the reasoning goes, the barrier might hold up better under exercise stress. Whether the reasoning is right is exactly what the trial was designed to test.
What the Trial Did
The study was randomized and controlled, supplementing aerobically trained subjects with zeolite over a twelve-week period. Rather than relying on symptom questionnaires alone, it used objective biomarkers across several domains at once [1]:
- Intestinal barrier integrity. Markers of gut wall permeability.
- Inflammation. Circulating inflammatory markers.
- Redox biology. Oxidative stress and antioxidant status.
- Performance. Exercise performance parameters.
Twelve weeks is a defensible duration. It is long enough that a real effect on gut barrier adaptation had time to appear, and long enough to say something about tolerability during sustained use, which matters for any supplement someone would take through a training block.
What It Found, and What It Did Not
The result that drew attention was on intestinal barrier integrity. That is also where the study’s design was most directly pointed, so it is the finding the trial is best positioned to support.
Performance is where the story gets overstated in secondary coverage. A trial that measures performance alongside three other domains and finds its clearest signal in gut barrier markers is not a performance study with a positive result. Anyone reading this as evidence that zeolite makes you faster is reading past what was measured.
The other limits are the ordinary ones, and they are not small:
- It has not been convincingly replicated. A single trial, however well constructed, is a reason to keep investigating, not a reason to conclude.
- Sample sizes in this literature are modest. Biomarker studies in trained populations are usually small, which widens the uncertainty around any effect size.
- Biomarkers are not outcomes. A favorable movement in a permeability marker is not the same as fewer athletes having gastrointestinal trouble in a race. That gap has to be crossed by studies measuring what athletes actually care about.
- Product specificity. Findings apply to the material used in the trial. Clinoptilolite products differ in purity, particle size, and processing, and those differences are not cosmetic.
How This Fits With the Rest of the Zeolite Evidence
Put next to the broader clinoptilolite literature, this trial is unusual in two ways. It is in humans, and it measured something other than binding capacity.
The other well-known human clinoptilolite trial took a different angle, showing that purified clinoptilolite tuff taken alongside lead reduced how much of that lead was absorbed from the gut [3]. Both trials share an underlying theme worth noticing: what clinoptilolite has actually been shown to do in humans happens in the digestive tract. One study is about reducing absorption of something in the lumen, and the other is about the state of the gut wall itself. Neither describes zeolite circulating through the body doing something systemic.
That consistency is useful. It suggests the honest version of the zeolite story is a gut-level story, and claims that stray far from the digestive tract are running ahead of the evidence.
Practical Read for Athletes
If you are an endurance athlete with recurring gut symptoms in training or racing, the ordering that makes sense is:
- Fix fueling first. Carbohydrate concentration, osmolality, total fluid intake, and timing account for a large share of exercise gastrointestinal symptoms, and adjusting them costs nothing.
- Train the gut. Deliberately practicing race-day fueling in training improves tolerance. This is one of the better-supported interventions available.
- Address heat and pacing. Core temperature and intensity both drive the underlying blood flow redistribution.
- Rule out the medical causes. Persistent symptoms deserve a clinician, not a supplement stack. Some of what gets attributed to exercise is a diagnosable condition that exercise happens to reveal.
- Then, and only then, consider a supplement with one supporting trial behind it.
Zeolite at this point is a reasonable thing to be curious about and a poor thing to build a plan around. One trial in a small, specific population is the beginning of an evidence base rather than a conclusion.
A Note on the Evidence
The central study here is a single randomized trial in aerobically trained adults using biomarker endpoints, and it has not been replicated at scale. Biomarker changes do not automatically translate into changes in symptoms or outcomes. Zeolite supplements are not approved by the FDA to diagnose, treat, cure, or prevent any disease, and nothing here is medical advice. Persistent gastrointestinal symptoms during exercise are worth discussing with a physician or a sports dietitian, since several treatable conditions present that way.
Frequently Asked Questions
Does zeolite improve athletic performance?
The one randomized trial in trained adults measured performance parameters alongside gut barrier and inflammation markers, and performance was not where the meaningful signal appeared. The finding that drew attention was on intestinal barrier integrity. Treating zeolite as a performance supplement goes beyond what that trial supports.
What is exercise-induced leaky gut?
During prolonged or intense exercise, blood flow is redirected away from the digestive tract toward working muscle. That relative ischemia, combined with heat stress, can temporarily loosen the junctions between intestinal cells, allowing more material through the gut wall than usual. It is a recognized phenomenon in endurance athletes and is associated with the gastrointestinal symptoms common in long-distance racing.
Why does this trial matter more than other zeolite research?
Because most clinoptilolite research is in vitro, in livestock, or in rodents. This was a randomized, controlled trial in humans, using a defined supplementation period and objective biomarkers. Regardless of how you weigh the result, it sits at a level of evidence most zeolite claims never reach.
How long did participants take zeolite in the study?
The supplementation period ran twelve weeks, which is long enough to be a reasonable test of a sustained effect rather than an acute one.
Should endurance athletes take zeolite?
One trial is a starting point, not a settled answer, and it has not been replicated at scale. If gut symptoms during long events are the actual problem, the interventions with much stronger evidence are gut training, carbohydrate and fluid strategy, and heat acclimation. Those should come first, and a clinician or sports dietitian is the right person to work through them with.
References
- Effects of zeolite supplementation on parameters of intestinal barrier integrity, inflammation, redoxbiology and performance in aerobically trained subjects. Journal of the International Society of Sports Nutrition (2015). PMID 26500463
- Exploring the gut-exercise link: A systematic review of gastrointestinal disorders in physical activity. World Journal of Gastroenterology (2025). PMID 40539198
- Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans. Scientific Reports (2021). PMID 34285282
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
